FDA: Pancreatic enzyme drugmakers must submit NDA

Deucravacitinib demonstrated a statistically significant inhibition of radiographic progression compared to placebo.

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Using the “Psoriasis and Beyond” survey design, researchers addressed patients’ awareness of psoriatic diseases and their associated comorbidities.

In this episode of the podcast, Shawn and Jesse discuss the benefits of being easy to do business with.

PET and autopsy assays suggest that Alzheimer disease (AD) and non-AD tau pathologies could be the underlying cause of some late-life mood disorders.

Whether it is a kitchen mishap or backyard injury, pharmacists are key in helping patients choose the right OTC first aid products for fast, effective care.